Antibody responses to hepatitis C virus hypervariable region 1: Evidence for cross-reactivity and immune-mediated sequence variation

Hepatology

Volumn 30, Issue 2, 1999, Pages 537-545

  Mondelli, Mario U ^a,b   Cerino, Antonella ^a   Lisa, Antonella ^c   Brambilla, Sabrina ^b   Segagni, Laura ^a   Cividini, Agostino ^a   Bissolati, Morena ^a   Missale, Gabriele ^d   Bellati, Giorgio ^e   Meola, Annalisa ^f   Bruniercole, Bruno ^f   Nicosia, Alfredo ^f   Galfrè, Giovanni ^f   Silini, Enrico ^b  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c CNR   (Italy)

^d UNIVERSITY HOSPITAL OF PARMA   (Italy)

^e OSPEDALE NIGUARDA CA GRANDA   (Italy)

^f IRBM   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G; OLIGOPEPTIDE; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS RNA;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOME; HEPATITIS C VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; CHILD; CROSS REACTIONS; EPITOPE MAPPING; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; VIRAL ENVELOPE PROTEINS;

EID: 0032783678     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300233     Document Type: Article

References (18)

1. Anonymous. National Institutes of Health Consensus Development Conference Panel Statement: Management of Hepatitis C. HEPATOLOGY 1997;26(Suppl):2S-10S.
2. Mondelli, MU. Is there a role for immune responses in the pathogenesis of hepatitis C? J Hepatol 1996;25:232-238.
3. Botarelli P, Brunetto MR, Minutello MA, Calvo P, Unutmaz D, Weiner AJ, Choo Q-L, et al. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 1993;104:580-587.
4. Koziel MJ, Dudley D, Wong JT, Dienstag JL, Houghton M, Ralston R, Walker BD. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 1992;149:3339-3344.
5. Ferrari C, Valli A, Galati L, Penna A, Scaccaglia P, Giuberti T, Schianchi C, et al. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. HEPATOLOGY 1994;19:286-295.
6. Wong DK, Dudley DD, Afdhal NH, Dienstag JL, Rice CM, Wang L, Houghton M, et al. Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection. J Immunol 1998;160:1479-1488.
7. Zibert A, Kraas W, Meisel H, Jung G, Roggendorf M. Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus. J Virol 1997;71:4123-4127.
8. Scarselli E, Cerino A, Esposito G, Silini E, Mondelli MU, Traboni C. Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (E2; gp70) hypervariable region 1 in hepatitis C viremic patients. J Virol 1995;69:4407-4412.
9. Cerino A, Bissolati M, Cividini A, Nicosia A, Esumi M, Hayashi N, Mizuno K, et al. Antibody responses to the hepatitis C virus (HCV) E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects. J Med Virol 1997;51:1-5.
10. da Silva-Cardoso M, Siemoneit K, Nemecek V, Epple S, Koerner K, Kubanek B. The serology of hepatitis C virus infection: antibody crossreaction in the hypervariable region 1. Arch Virol 1995;140:1705-1713.
11. Jackson P, Petrik J, Alexander GJM, Pearson G, Allain J-P. Reactivity of synthetic peptides representing selected sections of hepatitis c virus core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma. J Med Virol 1997;51:67-79.
12. Weiner AJ, Brauer MJ, Rosenblatt J, Richman KH, Tung J, Crawford K, Bonino F, et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 1991;180:842-848.
13. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infection. Proc Natl Acad Sci U S A 1992;89:3468-3472.
14. Taniguchi S, Okamoto H, Sakamoto M, Kojima M, Tsuda F, Tanaka T, Munekata E, et al. A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. Virology 1993;195:297-301.
15. Lechner S, Rispeter K, Meisel H, Kraas W, Jung G, Roggendorf M, Zibert A. Antibodies directed to envelope proteins of hepatitis C virus outside of hypervariable region 1. Virology 1998;243:313-321.
16. Rosa D, Campagnoli S, Moretto C, Guenzi E, Cousens L, Chin M, Dong C, et al. A quantitative test to estimate neutralizing antibodies to hepatitis C virus: cytofluorometric assessment of envelope glycoprotein E2 binding to target cells. Proc Natl Acad Sci U S A 1996;93(5):1759-1763.
17. Pileri P, Yasushi U, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, et al. Binding of hepatitis C virus to CD81. Science 1998;282:938-941.
18. Zibert A, Meisel H, Kraas W, Schulz A, Jung G, Roggendorf M. Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus. HEPATOLOGY 1997;25:1245-1249.